Induction Healthcare Group PLC represents values of innovation, excellence, and patient-centered care. The company's corporate philosophy is centered around leveraging technology to transform healthcare delivery and improve patient outcomes. Induction Healthcare Group PLC prioritizes building strategic partnerships, enhancing clinical communication, and facilitating secure collaboration among healthcare professionals. With a strong focus on digital solutions, the company aims to streamline workflows, increase efficiency, and enhance overall patient experience. By embracing technological advancements, Induction Healthcare Group PLC is committed to revolutionizing the healthcare industry and empowering healthcare providers to deliver the highest standard of care.

Induction Healthcare Group PLC is primarily present in the United Kingdom.

Some significant milestones achieved by Induction Healthcare Group PLC include: 1. Successful IPO in 2018, listing on the London Stock Exchange's AIM market. 2. Acquisition of Zesty Limited, a leading digital health booking service provider, in 2019. 3. Introduction of the Induction Switch platform, allowing clinicians to securely communicate and share patient information in real-time. 4. Partnership with NHS trusts and private clinics, expanding their customer base and reach within the healthcare sector. 5. Recognition as one of the top digital health companies in the UK, receiving various industry accolades for innovation and technological advancements. These achievements demonstrate Induction Healthcare Group PLC's commitment to revolutionizing healthcare through digital solutions and their ability to grow and adapt in a competitive market.

Induction Healthcare Group PLC, founded in 2011, is a leading healthcare technology company based in the United Kingdom. The company specializes in developing innovative solutions to transform healthcare processes and enhance patient care. With a focus on secure messaging and task management, Induction has developed a comprehensive platform designed to streamline communication within healthcare organizations. The company's history is marked by continuous growth and successful partnerships with prominent healthcare providers globally. Induction Healthcare Group PLC strives to revolutionize the way healthcare professionals collaborate, helping healthcare organizations improve efficiency, productivity, and ultimately, patient outcomes.

The main competitors of Induction Healthcare Group PLC in the market include [competitor 1], [competitor 2], and [competitor 3]. These competitors operate in the same industry as Induction Healthcare Group PLC and offer similar products and services. However, Induction Healthcare Group PLC differentiates itself through its innovative solutions, strong market reputation, and dedication to customer satisfaction.

Induction Healthcare Group PLC is primarily active in the healthcare industry.

The business model of Induction Healthcare Group PLC is focused on providing a comprehensive digital platform for healthcare professionals. Induction offers a range of solutions to enhance communication, collaboration, and workflow optimization in healthcare settings. Their flagship product, Induction Switch, enables secure messaging, task management, and clinical collaboration for healthcare teams. Additionally, Induction offers booking and scheduling services through their Induction Zesty platform. By leveraging technology to streamline and improve healthcare processes, Induction Healthcare Group PLC aims to enhance patient care, increase efficiency, and drive positive outcomes in the healthcare industry.

Det Induction Healthcare Group P/E-forhold er -2,85.

Induction Healthcare Group KUV er 0,68.

AlleAktien Kvalitetsscore for Induction Healthcare Group er 3/10.

Den Induction Healthcare Group omsætning er 13,65 mio. GBP.

Den Induction Healthcare Group indtjening er -3,26 mio. GBP.

Induction Healthcare Group PLC is a rapidly developing British technology company specializing in the field of clinical communication and collaboration. It offers a range of products and services to support medical professionals in working more effectively and productively. Hospitals seeking to improve their communication and collaboration processes are one of the key target audiences for Induction Healthcare Group PLC. The company provides a cloud-based platform called "Induction" that offers various tools such as messaging, video and voice calls, task management, and real-time collaboration to enhance clinical collaboration. This platform is particularly useful for teams working across different stations who need to quickly and securely share information. Induction also has a mobile app called "Induction Switch" that provides a fast and easy way to share important clinical information and tasks. The app enables real-time communication between doctors, nursing staff, and patients, facilitating collaboration within the department. Another important product of Induction Healthcare Group PLC is "Induction Zesty." This is a clinical patient management platform that helps patients access their health information and appointments, allowing them to better track their treatment. The platform also includes a secure messaging feature for communication between patients and medical staff. Induction Healthcare also has a newer division, Induction Monocyte, which provides an AI-based platform for predicting sepsis, a life-threatening infection that frequently occurs in hospital patients. The platform is based on machine learning algorithms that enable more precise diagnosis of sepsis, leading to improved treatment outcomes. The business model of Induction Healthcare Group PLC is based on a licensing model that allows hospitals and medical facilities to access the Induction platform. Additionally, the company provides training and support for medical staff to ensure effective utilization of its products. Overall, Induction Healthcare Group PLC has developed a diverse portfolio of products and services aimed at improving the collaboration and coordination of medical personnel, ultimately enhancing both medical outcomes and the efficiency of hospitals and medical facilities.

Induction Healthcare Group udbetaler et udbytte på 0 GBP fordelt over udbetalinger om året.

Udbyttet kan for nuværende ikke beregnes for Induction Healthcare Group, eller selskabet udbetaler ikke udbytte.

ISIN'en for Induction Healthcare Group er GB00BJ0M3545.

Tickeren for Induction Healthcare Group er INHC.L.

I løbet af de sidste 12 måneder betalte Induction Healthcare Group en dividende på . Dette svarer til et dividendeudbytte på omkring . For de kommende 12 måneder vil Induction Healthcare Group sandsynligvis betale en dividende på 0 GBP.

Udbytteafkastet for Induction Healthcare Group er i øjeblikket .

Induction Healthcare Group betaler kvartalsvis udbytte. Dette uddeles i månederne .

Induction Healthcare Group betalte udbytte hvert år i løbet af de sidste 0 år.

For de kommende 12 måneder forventes der dividender på 0 GBP. Dette svarer til et dividendeafkast på 0 %.

Induction Healthcare Group bliver tildelt sektoren 'Sundhed'.

For at modtage det seneste udbytte på Induction Healthcare Group fra den 21.7.2024 på 0 GBP, skulle du have haft aktien i din portefølje før ex-datoen den 21.7.2024.

Udbetalingen af det sidste udbytte blev foretaget den 21.7.2024.

I løbet af 2023 udbetalte Induction Healthcare Group 0 GBP i form af dividender.

Udbytterne fra Induction Healthcare Group udbetales i GBP.